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Introduction
Sub-Saharan Africa and other areas of the world are facing 
the biggest chronic pandemic known to modern man. 
The estimated infected number of patients with human 
immunodeficiency virus (HIV)/acquired immune deficiency 
syndrome (AIDS) is growing, although the rate has now 
peaked.1 At any stage of the disease, 75–100% of patients with 
HIV/AIDS have a head and neck manifestation.2 Anaesthetists 
are especially vulnerable, as they come into contact with 
contaminated blood and body fl uids, but they also have to 
manipulate and maintain a compromised airway. Therefore, 
it is imperative to note and recognise important clinical 
signs. Although gloves and masks should be worn routinely 
when administering anaesthesia, a knowledge or high index 
of suspicion of HIV/AIDS infection is preferable to protect 
healthcare workers in theatre.3,4 The immune-compromised 
patient also benefi ts from stricter asepsis control.
HIV is a lentivirus of the retrovirus family. It is unique as it 
contains two enzymes, reverse transcriptase and viral integrase, 
which allow for incorporation of the host’s DNA into the virus’ 
mRNA, allowing replication of the invader virus. In the process, 
the host CD4 cells, which normally augment and orchestrate an 
immune response in the host, are destroyed. It follows that the 
lower the CD4 count, the worse the patient’s overall immunity. 
This means that there is overgrowth of opportunistic and other 
infections, as well vasculitis and the exacerbation of cancer. 
Therefore, a CD4 count may be used to stage the severity of the 
disease (not reliable in children) (Table 1).5 
It is not always possible to obtain laboratory confi rmation of 
either the disease, or a CD4 count, in the developing world. Oral 
fungal colonisation, one of the most common opportunistic 
observed infections in adults and children with HIV, is of 
more prognostic value.6 Oral mucosal lesions alone are poor 
predictors of HIV infection in populations where the prevalence 
of HIV is low. But oral lesions indicate HIV infection and enable 
staging of the disease in areas of high prevalence. These lesions 
parallel a decline in the number of CD4 cells and an increase in 
the viral load, and are independent indicators of the presence 
of HIV infection.7 Oral lesions may also be used to evaluate the 
entry or end-points in therapy and/or vaccine trials. The World 
Health Organization (WHO) has staged this disease according 
to clinical severity (Table 2). For the sake of simplicity, this article 
will only discuss head and neck pathology. Table 3 highlights 
the pathology that will be discussed in more detail.
Infections
Cutaneous
Severe facial rashes are commonly seen in HIV/AIDS 
patients. These manifestations range from severe acne to 
other dermatitidides, and probably relate to the degree of 
immunocompromise. Seborrhoeic dermatitis is very common 
and involves the face and scalp, and can also aff ect the external 
ear.8 Candidiasis in the corners of the mouth (cheilitis or 
perleche) is almost pathognomonic in South African practice 
(Figure 1). The only relevance to the anaesthetist is that the 
anaesthetic face mask may cause the skin to further excoriate 
and bleed.
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As the name suggests, Molluscum contagiosum is extremely 
contagious, and the face may be heavily infected. Hand gloves 
are essential during contact with these patients (Figure 2).
Oropharyngeal manifestations
Oral candidiasis
A clinic in Lesotho reports that 75% of patients with HIV/
AIDS have oral lesions.9 Oral candidiasis has been consistently 
reported as the most prevalent HIV-associated oral lesion (54%) 
in all age groups.7,10,11 Oral candidiasis may be a presenting 
sign of HIV, and becomes grossly exaggerated as the immune 
system is further compromised.12 Children have immature 
immune systems and potential suppressed cellular immunity. 
Therefore, candidial overgrowth may become so extensive 
around the laryngeal framework that upper airway obstruction 
may necessitate intubation and ventilation in the intensive 
care unit.13,14 Children and adults may also develop epiglottitis. 
It should also be noted that even seemingly innocuous oral 
presentation, structures such as the larynx, trachea, bronchi 
and oesophagus (in 20-40% of AIDS patients), can be heavily 
contaminated (Figure 3). These patients often present with 
intense dysphagia, severe odynophagia, chest pain and 
hoarseness, and sometimes stridor and aspiration.15 This pain 
is caused by pseudomembranes, erosions and ulcers on the 
oesophageal and bronchial mucosa. Strictures of both the 
bronchi and oesophagus are common in these patients, and the 
pathogenesis of the fi brosis is thought to be due to a chronic 
infl ammatory response within the mucosa from toxins and 
enzymes secreted by the fungus.15 
Oral hairy leukoplakia (OHL) on the lateral side of the tongue is 
caused by the Ebstein-Barr virus (EBV). These lesions cannot be 
scraped off  the mucosa. OHL is not seen often in South Africa, 










Figure 1: Cheilitis at the corners of the mouth (Source: Department of 
Maxillo-Facial Surgery, University of Pretoria)
Figure 2: Molluscum contagiosum (Source: Department of Maxillo-
Facial Surgery, University of Pretoria)







Performance scale 1: Asymptomatic with normal activity
WHO
stage 2
Weight loss < 10% of body weight
Minor mucocutaneous manifestations*
Herpes zoster shingles*
Recurrent upper airway infections*
Performance scale 2: Symptomatic with normal activity
WHO
stage 3
Weight loss > 10% of body weight



































Performance scale 4: In bed > 50% of daytime during the past 
month
AIDS: acquired immune deficiency syndrome
HIV: human immunodeficiency virus
WHO: World Health Organization
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but is prevalent in the USA. South Africa is thought to have a 
diff erent strain of HIV. OHL signifi es a poorer prognosis, as it 
usually heralds a lower CD4+ count and a sharp increase in viral 
load. Eighteen per cent of patients will seroconvert to full blown 
AIDS within 18 months.10 
Oral ulcers
These ulcers are common, manifesting because of either 
infection (herpes simplex and varicella zoster) or an abnormal 
immune response (giant aphthous ulcers). Aphthous ulcers are 
precipitated by psychological and socio-economic trauma and 
nutritional defi ciencies.6,7,11 It is relevant to the anaesthetist that 
when these ulcers are giant and multiple, they signal disease 
progression. Patients presenting in theatre may be debilitated 
and dehydrated as eating and drinking may cause extreme 
pain. Long-standing herpetic ulcers that persist for one month 
or more are also indicative of advanced disease.10,16 
Human immunodeficiency virus-associated gum disease 
HIV-associated gingivitis is prevalent. The final stage of 
gingivitis is periodontal disease with bone re-absorption, 
resulting in loose teeth. A straightforward endotracheal 
intubation may result in teeth simply falling out of their 
sockets.9 The patient often also presents to the doctor because 
of bleeding gums and petechiae on the entire oral musosa. Ten 
per cent of HIV patients and 33% of AIDS patients have chronic 
thrombocytopenia. The pathogenesis of thrombocytopenia 
in HIV is multifactorial, involving both defects in platelet 
production (late disease) and accelerated platelet destruction 
(early disease).17,18 Clinically, HIV-related thrombocytopenia 
(HIV-TP) is similar to immune thrombocytopenia, but only 8% 
of patients with HIV-TP have severe bleeding, despite very low 
platelet counts.17 The reason for this may be the presence of 
thrombotic microangiopathy in HIV disease.19-22 Therefore, in 
endemic areas, the anaesthetist should always check for oral 
petechiae prior to placing nasoendotracheal tubes or neuraxial 
blocks. Major elective surgery should not be performed in 
thrombocytopenic patients unless platelets are available.
Upper respiratory tract infections 
Inflammation in lymphoid tissue in Waldeyer’s ring
Hypertrophy of lymphoid tissue in Waldeyer’s ring (adenoidal, 
tonsillar and lingual tonsillar lymph tissue) is very prevalent 
in children with HIV/AIDS, and may cause dysphagia and 
obstructive sleep apnoea, as well as total airway obstruction 
in some cases.23 Adults rarely have adenoidal tissue, but in 
the early stages of HIV infection the prevalence ranges from
56–88%. As the disease progresses, patients are no longer able 
to mount an immune response and the adenoids disappear. 
Care should be taken with the passing of nasogastric, 
endotracheal and temperature probes through the nose.
Sinusitis
Sinusitis is prevalent and may be severe. It may be acute or 
chronic, with or without mucopurulent postnasal discharge. 
Aggressive sinonasal disease may be caused by opportunistic 
infections of aspergillosis and mucormycosis, both of which 
have the affi  nity to invade blood vessels. Chronic sinusitis is 
defi ned as a persistent infection lasting 12 weeks or more, 
and correlates with a CD4+ count of below 200/mm3. The 
placement of nasogastric and nasal endotracheal tubes should 
be avoided.24 
Laryngeal tuberculosis
Co-infection with HIV and tuberculosis is not uncommon. 
Patients with laryngeal tuberculosis usually present 
with hoarseness. As tuberculosis is known as the “great 
masquerader”, these lesions often appear to be a malignancy, 
and direct layngoscopy is scheduled for theatre. This is a threat 
to the entire team, as the usually untreated lesion is highly 
contagious.
Laryngeal tuberculosis lesions are not uniform. However, 
the posterior commissure is often aff ected. The entire region 
may be oedematous, with bulky arytenoids and a greyish 
exudate over the vocal cords which appears to be moth-eaten. 
Granulomatous lesions are also frequently seen25 (Figure 4).
Deep cervical neck abscesses (Ludwig’s angina)
Deep cervical neck abscesses are discussed in the section on 
expanding neck masses.
Lower respiratory tract infections
Pulmonary tuberculosis
Pulmonary tuberculosis is the scourge of our time, and 
the explosion of cases in recent years is undoubtedly a 
consequence of the uncontrolled HIV epidemic in the last two 
decades of the previous century. South Africa has one of the 
highest infectivity rates of Mycobacterium tuberculosis in the 
world. The spread of M. tuberculosis in the general population 
has exponentially risen with increased immunosuppression 
from HIV.26 In addition, Mycobacterium resistance [multidrug-
resistant tuberculosis (MDR-TB) or extensively drug-resistant 
tuberculosis (XDR-TB)] is increasing.27,28 Co-infection with HIV 
Figure 3: Candidiasis of the mouth (Source: Department of Maxillo-
Facial Surgery, University of Pretoria)
Figure 4: Laryngeal tuberculosis (Source: Department of Maxillo-Facial 
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and tuberculosis causes the exacerbation of both diseases, 
while the toxic eff ects and interactions of drug therapy may 
add to mortality and morbidity.29-33 Healthcare workers in 
South Africa who have been exposed to MDR-TB and XDR-
TB appear to have a higher infectivity rate than the general 
population. Coughing is a physiological refl ex designed to clear 
the respiratory tract of debris, including infectious material, 
and is an extremely efficient way of initiating an aerosol-
airborne infection.34 The cough-generated aerosol particles of 
patients with open untreated pulmonary tuberculosis may be 
> 10 colony-forming units (CFUs), and as these bacilli are large, 
with a short trajectory, they may remain suspended in the 
atmosphere for up to six hours or longer. Possibly, tuberculosis 
bacilli may accumulate around the patient’s head where 
the anaesthesiologist, surgeon and nurses are standing. An 
additional concern is that tuberculosis has always been known 
as the “great masquerader”, and cases that have been assumed 
to be malignancies or simple infections have been proved to be 
“open” pulmonary tuberculosis. Personal protective equipment, 
such as N95® face masks, may not be in place or eff ective. 
Therefore, theatre air conditioning units and fi lters need to 
adhere to strict WHO guidelines, and research should be carried 
out on additional fi ltering in theatre.35,36 
The chest X-ray picture of a patient with pulmonary 
tuberculosis, co-infected with HIV may not appear to be similar 
to that traditionally seen with tuberculosis.37
Expanding head and neck masses
Ninety-one per cent of HIV-infected patients have an enlarged 
neck mass. The evaluation of neck mass in this population 
is complicated by the frequent presence of opportunistic 
pathogens and neoplasms that are unique to HIV infection. 
These masses can be classifi ed into four categories, namely HIV 
lymphadenopathy and parotid disease; infectious processes 
resulting in deep cervical neck abscesses (Ludwig’s angina); 
neoplasms; and aneurysms caused by vasculitis.24 
Lymphadenopathy and parotid enlargement
In the early stages of the disease, persistent generalised 
lymphadenopathy and parotid enlargement may be seen. 
Persistent generalised lymphadenopathy is classified as 
the presence of lymphadenopathy in two sites other than 
inguinal for a period longer than six months. Initially, in 
early HIV infection, a prodromal flu-like illness occurs, but 
during the seroconversion phase, 70% of patients develop 
persistent generalised lymphadenopathy.2,24 Lymph nodes 
may be visible in the posterior triangle and the submental 
areas. The lymphadenopathy disappears as the immunity 
progressively weakens and the architecture of the lymph nodes 
becomes destroyed in the later stages of the disease. Obvious 
lymphadenopathy (scrofula) may also be an extrapulmonary 
tuberculosis manifestation.
Uni- or bilateral parotid enlargement, also an early presenting 
sign in HIV, occurs because of exaggerated lymphoepithelial 
cyst formation within the capsule of the gland, and is strongly 
associated with persistent generalised lymphadenopathy.9 
The resultant square-looking face has no clinical signifi cance 
other than alerting clinicians to possible HIV infection, and 
the possibility of this being cosmetically unacceptable to the 
patient (Figure 5).24
Infectious processes
Deep cervical abscesses in the neck (Ludwig’s angina) 
Ludwig’s angina is always a concern, even in healthy patients, 
as gross swelling around the face and neck may make 
endotracheal intubation hazardous. However, the problem 
may be compounded by massive abscesses extending to 
the arm and chest wall in immune-compromised patients. 
A review by Ovassapian et al38 recommends that adults with 
cervical abscesses undergo an awake tracheal intubation using 
a flexible bronchoscope. The experience in our institution 
confi rms the success of this technique. These patients often 
have a copious amount of pus and saliva pouring from their 
mouths. These secretions not only impede visualisation with 
the fl exible bronchoscope, but also dilute the local anaesthetic, 
resulting in inadequate topicalisation of the oral, pharyngeal 
and laryngeal mucosa. Aggressive suctioning and the use of 
an antisialogogue, at least 15 minutes prior to topicalisation, is 
essential. Technically, an awake tracheostomy is usually diffi  cult 
as up to 15 cm of indurated tissue may overlie the trachea.
Bulk tumours
Tumours around the head and neck are not uncommon, and 
invariably threaten airway patency and management. The 
reason may be that HIV replicates, using a DNA intermediate 
that integrates into the host’s chromosomal DNA, and therefore 
makes the virus inherently mutagenic. Existing tumours are also 
exacerbated owing to poor immunity.
Lymphomas, sarcomas and carcinomas are commonly 
mentioned in HIV/AIDS literature. The incidence of lymphomas 
may be increased 60- to 200-fold in HIV-positive individuals. 
Non-Hodgkin’s lymphoma, although only present in 4% of 
infected patients, is an AIDS-defi ning illness. The pathogenesis 
of non-Hodgkin’s lymphoma remains obscure, but there has 
been considerable interest in the role of the EBV as 50% of 
AIDS-related tumours demonstrate EBV genomes. Survival rates 
are low.39,40 Although only 3% of all non-Hodgkin’s lymphoma 
occurs in the oral cavity, the impact on the airway may be 
extreme. The clinical appearance varies, but often presents as a 
rapidly enlarging mass associated with bony destruction. 
Classical Burkitt’s lymphoma, which accounts for 30% of AIDS-
related lymphomas, is the other relatively common lymphoma 
seen around the head and neck region. In contrast to other 
AIDS-related lymphomas, it often occurs early in the course of 
the HIV infection. These tumours grow to an enormous size, 
and the bulk mass around the jaw may cause major airway 
management problems.41
Figure 5: Bilaterally enlarged parotid glands result in a square-shaped 
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Kaposi’s sarcoma 
This is the most common malignancy observed in patients with 
AIDS. Kaposi’s sarcoma may start off  as a fl at lesion, and rapidly 
grow into a large haemorrhagic tumour.42-44 Other cutaneous 
Kaposi’s sarcoma may be a clue to respiratory tract involvement. 
Two thirds develop around the head and neck, and 20% in the 
respiratory tract where 65% occur around the supraglottic area, 
47% around the glottis, and 18% infraglottically. Therefore, 
airway impairment and compromise depends on the location 
of the lesion. The anaesthetist may be unable to view the 
larynx owing to the bulk mass eff ect or due to uncontrollable 
bleeding resulting from instrumentation. Awake tracheostomy 
is advisable if the tumour is causing respiratory distress, or if 
potential haemorrage is a consideration (Figure 6). 
An otolaryngoscopy consultation is advisable, as well as 
a detailed upper and lower respiratory tract history and 
examination. An attempt should be made to shrink the tumour 
prior to an elective procedure using chemotherapy, thalidomide 
and radiation.45,46 
Other carcinomas may grow and disseminate more rapidly in 
infected patients. Compared to the general population, HIV-
infected patients are more likely to develop basal cell and 
squamous carcinomas. Squamous cell carcinomas seem to 
have a predilection for developing in the head and neck region 
and present later in HIV. Basal cell carcinomas present more 
frequently on the trunk, and are seen throughout the disease.
Vasculitis4,6
The relationship between vascular disease and HIV infection 
is well documented. The precise pathogenesis of the vasculitis 
is still unclear. HIV-related aneurysms have several histological 
features that distinguish them from degenerative and infective 
aneurysms. The principal feature is occlusion of the vasa 
vasorum by infl ammatory cell infi ltrate. However, the precise 
mechanism for HIV-related disease is still unclear. A hypothesis 
exists of bacteraemia resulting in immune depression, with 
secondary mycotic aneurysms or weakening of the arterial wall, 
caused by the direct action of the virus itself or by immune-
complex mechanisms, or by ischaemia of the vessel wall 
resulting from occlusion of the vasa vasorum.47 
Clues that are suggestive of vasculitis are:
• Younger patients presenting with HIV-related vascular disease.
• The absence of risk factors for atherosclerosis.
• Multiple aneurysms and other features of immunodefi ciency. 
Vessel wall aneurysms appear to have a predilection for carotid 
arteries (Figure 7), and there is a danger that these patients will 
be booked for incision and drainage for what appears to be a 
bacterial abscess. 
Airway compromise resulting from HIV treatment 
with antiretroviral therapy
Although ART has unequivocally saved millions of lives, 
paradoxically it may cause airway compromise.48 After 
the initiation of ART, the CD4+ cell count begin to rise, 
reactivating the immune system. This results in rapid lymph 
node enlargement in the neck, which may cause airway 
embarrassment. This phenomenon is known as immune 
reconstitution infl ammatory syndrome.49,50 
ART is also known to cause lipodystrophy or abnormal fat 
distribution.51 This pathology occurs in ~ 33% of patients. 
Factors that infl uence the onset are:
• The duration of the drug therapy.
• Stavudine therapy.
• Zidovudine therapy.
• Protease inhibitors: These cause dyslipidaemia, but rarely 
morphological changes.
It is common for facial wasting to occur, making it diffi  cult 
for the face mask to be placed. The extreme buff alo hump 
that forms at the base of the neck may hamper endotracheal 
intubation.
Declaration — Patients who receive treatment from the 
Department of Maxillo-Facial Surgery, University of Pretoria, 
have to sign consent allowing photographs of their pathology 
to be used for teaching.
Conclusion
The anaesthetist is uniquely positioned to detect manifestations 
of HIV/AIDS around the head and neck. Although the 
anaesthetic course is unlikely to change for most patients, the 
manifestations may provide a clue with regard to the patient’s 
HIV status. Airway management may be difficult in some 
patients owing to bulk masses, such as tumours, infections and 
aneurysms. At times, it may even be life threatening. It has to 
be remembered that this disease has other systemic eff ects, 
such as cardiac, pulmonary, haemopoietic and central nervous 
system manifestations, and that these may influence the 
outcome of anaesthesia. 
Figure 6: Kaposi’s sarcoma of the tongue (Source: Department of 
Maxillo-Facial Surgery, University of Pretoria)
Figure 7: Carotid artery aneurysm in a young woman (Source: 
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The risk of contracting tuberculosis is the most pressing 
concern for the modern-day anaesthetist. This disease is 
exponentially rising and becoming resistant to treatment. 
Traditional methods of protection that rely on circulating air 
(air conditioning) with fi lters may now no longer be adequate. 
Particulate respirators (N95®) masks, if appropriately sized and 
positioned correctly, will fi lter 99.5% of mycobacteria. However, 
these masks require a “fi t test” to ensure a tight seal, and are 
extremely uncomfortable to wear for a prolonged period.52
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